Literature DB >> 8990061

Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.

D Tarsy1.   

Abstract

Seventy-six consecutive patients with cervical dystonia. (CD) treated with botulinum toxin were assessed with the Tsui rating scale, the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), and a global scale of improvement. Tsui, TWSTRS, and TWSTRS subscale scores all showed significant improvement. Tsui and TWSTRS score reduction rates correlated significantly with each other, and each correlated with the global scale. Analysis of these scales and TWSTRS subscales indicates that an objective scale of severity such as either the Tsui rating scale or TWSTRS severity subscale used in conjunction with the TWSTRS pain subscale adequately assesses improvement of CD following treatment with botulinum toxin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990061     DOI: 10.1002/mds.870120117

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

1.  Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.

Authors:  D Ranoux; C Gury; J Fondarai; J L Mas; M Zuber
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 2.  Botulinum toxin type A versus anticholinergics for cervical dystonia.

Authors:  J Costa; C Espírito-Santo; A Borges; J J Ferreira; M Coelho; C Sampaio
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

3.  Predictable variables for short- and long-term botulinum toxin treatment response in patients with cervical dystonia.

Authors:  Andre C Felicio; Clecio Godeiro-Junior; Patricia de Carvalho Aguiar; Vanderci Borges; Sonia M A Silva; Henrique B Ferraz
Journal:  Neurol Sci       Date:  2009-05-26       Impact factor: 3.307

Review 4.  Dystonia rating scales: critique and recommendations.

Authors:  Alberto Albanese; Francesca Del Sorbo; Cynthia Comella; H A Jinnah; Jonathan W Mink; Bart Post; Marie Vidailhet; Jens Volkmann; Thomas T Warner; Albert F G Leentjens; Pablo Martinez-Martin; Glenn T Stebbins; Christopher G Goetz; Anette Schrag
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

5.  Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology.

Authors:  Cynthia L Comella; Susan H Fox; Kailash P Bhatia; Joel S Perlmutter; Hyder A Jinnah; Mateusz Zurowski; William M McDonald; Laura Marsh; Ami R Rosen; Tracy Waliczek; Laura J Wright; Wendy R Galpern; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2015-04-06

6.  Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients.

Authors:  Steven E Lo; Axel J Rosengart; Roberta L Novakovic; Un Jung Kang; Darshan N Shah; Mohsin A Khan; Arif Dalvi; Fernando D Goldenberg; R Loch Macdonald; Jeffrey I Frank
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 7.  Botulinum toxin type A therapy for cervical dystonia.

Authors:  Mafalda Castelão; Raquel E Marques; Gonçalo S Duarte; Filipe B Rodrigues; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2017-12-12

8.  Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia.

Authors:  R Hilker; M Schischniaschvili; M Ghaemi; A Jacobs; J Rudolf
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

9.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

10.  Motion analysis in cervical dystonia.

Authors:  Cristina Boccagni; Jacopo Carpaneto; Silvestro Micera; Sergio Bagnato; Giuseppe Galardi
Journal:  Neurol Sci       Date:  2008-11-29       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.